E Azoulay, F Pène, M Darmon, E Lengliné, D Benoit… - Blood Reviews, 2015 - infona.pl
The number of patients living with hematological malignancies (HMs) has increased steadily over time. This is the result of intensive and effective treatments that also increase the …
E Azoulay, F Pène, M Darmon, E Lengliné… - Blood …, 2015 - europepmc.org
The number of patients living with hematological malignancies (HMs) has increased steadily over time. This is the result of intensive and effective treatments that also increase the …
E Azoulay, F Pène, M Darmon, E Lengliné… - Blood …, 2015 - jvsmedicscorner.com
1. Background In most industrialized countries, the number of patients living with hematological malignancies (HMs) has increased steadily over the last two decades, for …
E Azoulay, F Pène, M Darmon, E Lengliné… - BLOOD …, 2015 - biblio.ugent.be
1. Background In most industrialized countries, the number of patients living with hematological malignancies (HMs) has increased steadily over the last two decades, for …
E Azoulay, F Pène, M Darmon, E Lengliné… - Blood …, 2015 - pubmed.ncbi.nlm.nih.gov
The number of patients living with hematological malignancies (HMs) has increased steadily over time. This is the result of intensive and effective treatments that also increase the …
E Azoulay, F Pène, M Darmon, E Lengliné… - Blood …, 2015 - jvsmedicscorner.com
1. Background In most industrialized countries, the number of patients living with hematological malignancies (HMs) has increased steadily over the last two decades, for …